Clinical Trials Directory

Trials / Unknown

UnknownNCT02108756

Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
272 (estimated)
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and Efficacy of L- Pantoprazole sodium to treat upper gastrointestinal ulcer bleeding.

Conditions

Interventions

TypeNameDescription
DRUGL-pantoprazole sodium2 injection L-pantoprazole sodium (40mg), Bid
DRUGPanmeiluAn injection Panmeilu (80 mg) + 1 branch placebo, Bid;

Timeline

Start date
2014-02-01
Primary completion
2015-04-01
Completion
2015-06-01
First posted
2014-04-09
Last updated
2014-04-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02108756. Inclusion in this directory is not an endorsement.